Suppr超能文献

一个控制核因子-κB亚基活性和功能的细胞周期调控网络。

A cell cycle regulatory network controlling NF-kappaB subunit activity and function.

作者信息

Barré Benjamin, Perkins Neil D

机构信息

Division of Gene Regulation and Expression, College of Life Sciences, University of Dundee, Dundee, Scotland, UK.

出版信息

EMBO J. 2007 Nov 28;26(23):4841-55. doi: 10.1038/sj.emboj.7601899. Epub 2007 Oct 25.

Abstract

Aberrantly active NF-kappaB complexes can contribute to tumorigenesis by regulating genes that promote the growth and survival of cancer cells. We have investigated NF-kappaB during the cell cycle and find that its ability to regulate the G1-phase expression of key proto-oncogenes is subject to regulation by the integrated activity of IkappaB kinase (IKK)alpha, IKKbeta, Akt and Chk1. The coordinated binding of NF-kappaB subunits to the Cyclin D1, c-Myc and Skp2 promoters is dynamic with distinct changes in promoter occupancy and RelA(p65) phosphorylation occurring through G1, S and G2 phases, concomitant with a switch from coactivator to corepressor recruitment. Akt activity is required for IKK-dependent phosphorylation of NF-kappaB subunits in G1 and G2 phases, where Chk1 is inactive. However, in S-phase, Akt is inactivated, while Chk1 phosphorylates RelA and associates with IKKalpha, inhibiting the processing of the p100 (NF-kappaB2) subunit, which also plays a critical role in the regulation of these genes. These data reveal a complex regulatory network integrating NF-kappaB with the DNA-replication checkpoint and the expression of critical regulators of cell proliferation.

摘要

异常激活的核因子-κB复合物可通过调控促进癌细胞生长和存活的基因来促进肿瘤发生。我们研究了细胞周期中的核因子-κB,发现其调控关键原癌基因G1期表达的能力受到IκB激酶(IKK)α、IKKβ、Akt和Chk1整合活性的调节。核因子-κB亚基与细胞周期蛋白D1、c-Myc和Skp2启动子的协同结合是动态的,在G1、S和G2期启动子占据和RelA(p65)磷酸化发生明显变化,同时伴随着从共激活因子募集到共抑制因子募集的转变。在G1和G2期,Chk1无活性,Akt活性是IKK依赖的核因子-κB亚基磷酸化所必需的。然而,在S期,Akt失活,而Chk1使RelA磷酸化并与IKKα结合,抑制p100(核因子-κB2)亚基的加工,p100亚基在这些基因的调控中也起关键作用。这些数据揭示了一个复杂的调控网络,将核因子-κB与DNA复制检查点及细胞增殖关键调节因子的表达整合在一起。

相似文献

1
A cell cycle regulatory network controlling NF-kappaB subunit activity and function.
EMBO J. 2007 Nov 28;26(23):4841-55. doi: 10.1038/sj.emboj.7601899. Epub 2007 Oct 25.
2
Regulation and function of IKK and IKK-related kinases.
Sci STKE. 2006 Oct 17;2006(357):re13. doi: 10.1126/stke.3572006re13.
4
Regulation of p53 tumour suppressor target gene expression by the p52 NF-kappaB subunit.
EMBO J. 2006 Oct 18;25(20):4820-32. doi: 10.1038/sj.emboj.7601343. Epub 2006 Sep 21.
5
Regulation of I(kappa)B kinase complex by phosphorylation of (gamma)-binding domain of I(kappa)B kinase (beta) by Polo-like kinase 1.
J Biol Chem. 2008 Dec 19;283(51):35354-67. doi: 10.1074/jbc.M806258200. Epub 2008 Oct 27.
8
Notch3 and pre-TCR interaction unveils distinct NF-kappaB pathways in T-cell development and leukemia.
EMBO J. 2006 Mar 8;25(5):1000-8. doi: 10.1038/sj.emboj.7600996. Epub 2006 Feb 23.
9
IKK-i/IKKepsilon controls constitutive, cancer cell-associated NF-kappaB activity via regulation of Ser-536 p65/RelA phosphorylation.
J Biol Chem. 2006 Sep 15;281(37):26976-84. doi: 10.1074/jbc.M603133200. Epub 2006 Jul 13.

引用本文的文献

3
Cyclin-dependent kinase 7/9 inhibitor SNS-032 induces apoptosis in diffuse large B-cell lymphoma cells.
Cancer Biol Ther. 2022 Dec 31;23(1):319-327. doi: 10.1080/15384047.2022.2055421.
4
Origin of the Functional Distinctiveness of NF-κB/p52.
Front Cell Dev Biol. 2021 Nov 23;9:764164. doi: 10.3389/fcell.2021.764164. eCollection 2021.
5
PKCδ/MAPKs and NF-κB Pathways are Involved in the Regulation of Ingenane-Type Diterpenoids from on Macrophage Function.
J Inflamm Res. 2021 Jun 25;14:2681-2696. doi: 10.2147/JIR.S306846. eCollection 2021.
7
Glycogen synthase kinase (GSK)-3 and the double-strand RNA-dependent kinase, PKR: When two kinases for the common good turn bad.
Biochim Biophys Acta Mol Cell Res. 2020 Oct;1867(10):118769. doi: 10.1016/j.bbamcr.2020.118769. Epub 2020 Jun 5.
8
Role of Nuclear Factor Kappa B (NF-κB) Signalling in Neurodegenerative Diseases: An Mechanistic Approach.
Curr Neuropharmacol. 2020;18(10):918-935. doi: 10.2174/1570159X18666200207120949.
9
The Screening Research of NF-B Inhibitors from Moutan Cortex Based on Bioactivity-Integrated UPLC-Q/TOF-MS.
Evid Based Complement Alternat Med. 2019 Mar 3;2019:6150357. doi: 10.1155/2019/6150357. eCollection 2019.
10
Overexpression of LASS2 inhibits proliferation and causes G0/G1 cell cycle arrest in papillary thyroid cancer.
Cancer Cell Int. 2018 Oct 1;18:151. doi: 10.1186/s12935-018-0649-1. eCollection 2018.

本文引用的文献

1
The selectivity of protein kinase inhibitors: a further update.
Biochem J. 2007 Dec 15;408(3):297-315. doi: 10.1042/BJ20070797.
2
Nuclear cytokine-activated IKKalpha controls prostate cancer metastasis by repressing Maspin.
Nature. 2007 Apr 5;446(7136):690-4. doi: 10.1038/nature05656. Epub 2007 Mar 18.
3
Functions of cyclin D1 as an oncogene and regulation of cyclin D1 expression.
Cancer Sci. 2007 May;98(5):629-35. doi: 10.1111/j.1349-7006.2007.00449.x. Epub 2007 Mar 14.
4
Integrating cell-signalling pathways with NF-kappaB and IKK function.
Nat Rev Mol Cell Biol. 2007 Jan;8(1):49-62. doi: 10.1038/nrm2083.
7
Regulation of p53 tumour suppressor target gene expression by the p52 NF-kappaB subunit.
EMBO J. 2006 Oct 18;25(20):4820-32. doi: 10.1038/sj.emboj.7601343. Epub 2006 Sep 21.
8
Evidence that the ATR/Chk1 pathway maintains normal replication fork progression during unperturbed S phase.
Cell Cycle. 2006 Oct;5(19):2203-9. doi: 10.4161/cc.5.19.3256. Epub 2006 Oct 1.
9
IKKalpha controls p52/RelB at the skp2 gene promoter to regulate G1- to S-phase progression.
EMBO J. 2006 Aug 23;25(16):3801-12. doi: 10.1038/sj.emboj.7601259. Epub 2006 Aug 10.
10
Cyld inhibits tumor cell proliferation by blocking Bcl-3-dependent NF-kappaB signaling.
Cell. 2006 May 19;125(4):665-77. doi: 10.1016/j.cell.2006.03.041.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验